Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone
Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Paradigm Biopharma (ASX:PAR) founder and managing director Paul Rennie about Paradigm arriving at its @pivotal” phase three trial, which will be examining outcomes of its flagshi...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| PA3 | Ann: Interest Details | 16/02/26 | 0 | 122 | |||
|
|||||||
| PA3 | Ann: Interest Details | 15/01/26 | 0 | 109 | |||
|
|||||||
| PA3 | Ann: Interest Details | 15/12/25 | 0 | 81 | |||
|
|||||||
| PA3 | Ann: Interest Details | 17/11/25 | 0 | 143 | |||
|
|||||||
| PA3 | Ann: Annual Report to shareholders | 29/10/25 | 0 | 107 | |||
|
|||||||
| PA3 | Ann: Interest Details | 15/10/25 | 0 | 106 | |||
|
|||||||
| PA3 | Ann: Interest Details | 15/09/25 | 0 | 192 | |||
|
|||||||
| PA3 | Ann: Interest Details | 15/08/25 | 0 | 226 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
| View More | |||||
ASX News